Retraction Volume 17, Issue 3 pp 883—884
Retraction of: Apigenin inhibits growth and migration of fibroblasts by suppressing FAK signaling
- 1 Reconstructive and Plastic Surgery, General Hospital of North Theater, PLA, Shenyang, P.R. China
Received: June 15, 2023 Accepted: March 26, 2025 Published: March 31, 2025
https://doi.org/10.18632/aging.206230How to Cite
Copyright: © 2025 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been retracted: Aging has completed its investigation of this paper. We found multiple instances of image reuse and overlap with images from unrelated papers from different institutions. Specifically:
Figure 1:
The transwell assay image in Figure 1G is a reuse of image in Figure 4G from the authors earlier paper [1];
The control transwell assay image in Figure 1H was reused in Figure 2G of the authors 2021 paper [2], which is already retracted;
The control transwell assay image in Figure 1H overlaps with an unrelated image in Figure 5D from already retracted paper [3];
The images in Figure 1H, 1I overlap with the images in Figure 5B from earlier published unrelated paper [4];
Also, images in Figure 1I overlap with the images in Figures 4A and 5B from already retracted paper [5];
Additionally, the images in Figure 1I were found in Figure 3F from concurrently published paper [6].
Figure 4:
The transwell assay images in Figure 4A, 4B were found to overlap with images in Figure 4F of [1], Figure 4C of [4], Figure 4D of [5], and Figure 3C from [6].
The corresponding author informed us that these overlaps were due to improper data storage in the laboratory and has applied for a retraction. Given these findings, the Editorial decision was to retract the paper. All authors have agreed to this retraction.
References
- 1. Song Y, Guo B, Ma S, Chang P, Tao K. Naringin suppresses the growth and motility of hypertrophic scar fibroblasts by inhibiting the kinase activity of Akt. Biomed Pharmacother. 2018; 105:1291–8. https://doi.org/10.1016/j.biopha.2018.06.103 [PubMed]
- 2. Xu Y, Guo B, Liu X, Tao K. miR-34a inhibits melanoma growth by targeting ZEB1. Aging (Albany NY). 2021; 13:15538–47. https://doi.org/10.18632/aging.203114 [PubMed] Retraction in: Aging (Albany NY). 2024; 16:13432–3. https://doi.org/10.18632/aging.206155 [PubMed]
- 3. Shan L, Liu W, Zhan Y. Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer. Aging (Albany NY). 2019; 11:7780–95. https://doi.org/10.18632/aging.102286 [PubMed] Retraction in: Aging (Albany NY). 2024; 16:12652–3. https://doi.org/10.18632/aging.206104 [PubMed]
- 4. Jiashi W, Chuang Q, Zhenjun Z, Guangbin W, Bin L, Ming H. MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression. Aging (Albany NY). 2018; 10:1294–305. https://doi.org/10.18632/aging.101468 [PubMed]
- 5. He M, Shen P, Qiu C, Wang J. miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN. Aging (Albany NY). 2019; 11:5744–56. https://doi.org/10.18632/aging.102157 [PubMed] Retraction in: Aging (Albany NY). 2024; 16:12953–4. https://doi.org/10.18632/aging.206128 [PubMed]
- 6. Chen J, Yan C, Yu H, Zhen S, Yuan Q. miR-548d-3p inhibits osteosarcoma by downregulating KRAS. Aging (Albany NY). 2019; 11:5058–69. https://doi.org/10.18632/aging.102097 [PubMed]